Corpus overview


Overview

MeSH Disease

Human Phenotype

Transmission

Seroprevalence

There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page




    Deteriorating Atrioventricular Block HP Atrioventricular Block MESHD in COVID-19 Suspected Patient after Receiving Initial Dose of Azythromycin and Hydroxychloroquine

    Authors: Billy Aditya Pratama; Afik Maulana Rachman; Vita Yanti Anggraeni; Erika Maharani; Ika Trisnawati; Bambang Sigit Riyanto; Anggoro Budi Hartopo

    id:10.20944/preprints202005.0190.v1 Date: 2020-05-11 Source: Preprints.org

    Coronavirus 2019 (COVID-19) is an infectious disease MESHD that is becoming a pandemic. Hydroxychloroquine in combination with azythromycin are among drugs currently in use to eradicate COVID-19. Despite concerns due to its potential cardiac toxicity MESHD, hydroxychloroquine is widely accepted in mild and moderate COVID-19 pneumonia HP pneumonia MESHD. In this case report, we report a case of a young Indonesian adult TRANS male TRANS with suspected COVID-19 pneumonia HP pneumonia MESHD who received hydroxychloroquine and azythromycin therapies and during 24 hour experienced deterioration of atrioventricular block MESHD atrioventricular block HP.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.